Related references
Note: Only part of the references are listed.Direct Medical Costs of Spinal Muscular Atrophy in the Catalonia Region: A Population-Based Analysis
Josep Darba
CLINICAL DRUG INVESTIGATION (2020)
The prevalence of spinal muscular atrophy carrier in China: Evidences from epidemiological surveys
Chao Li et al.
MEDICINE (2020)
Health, wellbeing and lived experiences of adults with SMA: a scoping systematic review
Hamish W. Y. Wan et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Carrier Frequency of Spinal Muscular Atrophy in a Large-scale Korean Population
Jong Eun Park et al.
ANNALS OF LABORATORY MEDICINE (2020)
Carrier frequency of spinal muscular atrophy in Thailand
Donniphat Dejsuphong et al.
NEUROLOGICAL SCIENCES (2019)
A review of the reproductive consequences of consanguinity
Oniya Olubunmi et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2019)
Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States
Cathy Lally et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy a literature review
Ingrid E. C. Verhaart et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Spinal Muscular Atrophy, types I and II: What are the differences in body composition and resting energy expenditure?
Simona Bertoli et al.
CLINICAL NUTRITION (2017)
Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
L. A. Nash et al.
CURRENT MOLECULAR MEDICINE (2016)
Developmental milestones in type I spinal muscular atrophy
Roberto De Sanctis et al.
NEUROMUSCULAR DISORDERS (2016)
Spinal muscular atrophy type III: Molecular genetic characterization of Turkish patients
Gamze Bora-Tatar et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2015)
The Genetics of Spinal Muscular Atrophy: Progress and Challenges
Michelle A. Farrar et al.
NEUROTHERAPEUTICS (2015)
Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies
Kristien Peeters et al.
BRAIN (2014)
Observational study of spinal muscular atrophy type I and implications for clinical trials
Richard S. Finkel et al.
NEUROLOGY (2014)
Spinal Muscular Atrophy: Development and Implementation of Potential Treatments
W. David Arnold et al.
ANNALS OF NEUROLOGY (2013)
Spinal Muscular Atrophy Carrier Frequency and Estimated Prevalence of the Disease in Moroccan Newborns
Jaber Lyahyai et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
Prospective cohort study of spinal muscular atrophy types 2 and 3
Petra Kaufmann et al.
NEUROLOGY (2012)
Spinal muscular atrophy: Clinical spectrum and genetic mutations in Pakistani children
Shahnaz Ibrahim et al.
NEUROLOGY INDIA (2012)
Non-5q spinal muscular atrophies The alphanumeric soup thickens
Basil T. Darras
NEUROLOGY (2011)
Child neuromuscular disease in Southern Norway: Prevalence, age and distribution of diagnosis with special reference to “non-Duchenne muscular dystrophy”
Svein-Erik Tangsrud et al.
CLINICAL GENETICS (2010)
Spinal muscular atrophy: mechanisms and therapeutic strategies
Christian L. Lorson et al.
HUMAN MOLECULAR GENETICS (2010)
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population
Fiona L. M. Norwood et al.
BRAIN (2009)
Spinal muscular atrophy: Advances in research and consensus on care of patients
Ching H. Wang et al.
Current Treatment Options in Neurology (2008)
Descriptive epidemiology of spinal muscular atrophy type I in Estonia
Eve Vaidla et al.
NEUROEPIDEMIOLOGY (2006)
New insights on the evolution of the SMN1 and SMN2 region:: simulation and meta-analysis for allele and haplotype frequency calculations
S Ogino et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Spinal muscular atrophy: Survival pattern and functional status
BHY Chung et al.
PEDIATRICS (2004)
Prevalence of neuromuscular diseases in Chinese children: A study in southern China
B Chung et al.
JOURNAL OF CHILD NEUROLOGY (2003)
Genetic testing and risk assessment for spinal muscular atrophy (SMA)
S Ogino et al.
HUMAN GENETICS (2002)
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
M Feldkötter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations
Y Martin et al.
HUMAN GENETICS (2002)
Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2
MD Mailman et al.
GENETICS IN MEDICINE (2002)
SMA carrier testing - validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion
H Scheffer et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
